Cargando…
Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Formosan Medical Association, Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800810/ https://www.ncbi.nlm.nih.gov/pubmed/36610888 http://dx.doi.org/10.1016/j.jfma.2022.12.018 |
_version_ | 1784861362439061504 |
---|---|
author | Kleebayoon, Amnuay Wiwanitkit, Viroj |
author_facet | Kleebayoon, Amnuay Wiwanitkit, Viroj |
author_sort | Kleebayoon, Amnuay |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9800810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Formosan Medical Association, Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98008102022-12-30 Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations Kleebayoon, Amnuay Wiwanitkit, Viroj J Formos Med Assoc Letter to the Editor Formosan Medical Association, Elsevier 2023-05 2022-12-30 /pmc/articles/PMC9800810/ /pubmed/36610888 http://dx.doi.org/10.1016/j.jfma.2022.12.018 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Kleebayoon, Amnuay Wiwanitkit, Viroj Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations |
title | Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations |
title_full | Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations |
title_fullStr | Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations |
title_full_unstemmed | Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations |
title_short | Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations |
title_sort | adverse effects and antibody responses following homologous and heterologous covid19 prime-boost vaccinations |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800810/ https://www.ncbi.nlm.nih.gov/pubmed/36610888 http://dx.doi.org/10.1016/j.jfma.2022.12.018 |
work_keys_str_mv | AT kleebayoonamnuay adverseeffectsandantibodyresponsesfollowinghomologousandheterologouscovid19primeboostvaccinations AT wiwanitkitviroj adverseeffectsandantibodyresponsesfollowinghomologousandheterologouscovid19primeboostvaccinations |